secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOLYTICS BIOTECH INC (ONCY)
CIK:        0001129928
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001104659-26-003815
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncolytics appoints EVP John McAdory and VP Biostatistics Yujun Wu, grants inducement awards
--------------------------------------------------------------------------------

- John McAdory named EVP Strategy & Operations; previously VP Clinical Ops at CG Oncology (Nasdaq: CGON).
- Yujun Wu named VP Head of Biostatistics; previously Head of Biostatistics at Morphic Therapeutic.
- Inducement awards: McAdory 500k options + 300k RSUs; Wu 300k options; exercise price $0.97.
- Appointments enhance execution for late-stage pancreatic, colorectal, and anal cancer trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1129928/000110465926003815/0001104659-26-003815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1129928/000110465926003815/tm263244d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-003815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer